TUESDAY, Aug. 20, 2019 -- Mutations in two genes -- BRCA1 and BRCA2 -- are known to significantly increase the risk of breast cancer, but experts have long debated which women should be tested for them.
New recommendations from the U.S. Preventive Services Task Force (USPSTF) may help clarify who can benefit most from a risk assessment test. Now, if a woman has a high risk, the task force is recommending that she see a genetic counselor and possibly be tested for the BRCA mutations.
TUESDAY, June 25, 2019 -- Experts agree that detecting breast cancer early offers a better outlook, but when to start screenings and how often to have them has changed repeatedly.
The goal has been to balance early detection with the distress of false positives that lead to unnecessary testing. But leading medical organizations differ regarding the guidelines, making it incumbent on women (and men at risk for breast cancer) to know all the options and take steps to make the right choice for them.